
Manitoba cabinet minister denies insider trading after selling shares in phone company blamed for 911 outage
The Tories filed a complaint with the ethics commissioner Tuesday, alleging Mike Moroz, minister of innovation and new technology, relied on information he only knew as government minister when he unloaded his stocks in the telecommunications company.
The party argued Moroz's actions violated Manitoba's conflict of interest act.
It seems that the "minister was privy to insider information that only he had in regards to a damning … Telus report in relation to the death of a Manitoban when the 911 system went down," Progressive Conservative Leader Obby Khan said.
However, Moroz is rejecting the allegations. He said he was solely acting on public information and media reports when he chose to sell his stocks in Telus, and his decision shows he was going "above and beyond" requirements from the ethics commissioner.
Shares sold 1 month after news
The Tory complaint centres on the timing of Moroz selling his shares.
Public disclosure records show he disposed of his Telus shares on May 13, one day before he named the company in question period for a 911 outage that prevented Dean Switzer's loved ones from reaching emergency dispatch centre. None of their more than 20 calls were answered.
Switzer, 55, died of a heart attack in his home outside Fisher Branch, Man., on March 23.
The story was initially reported by CTV News on Apr. 8 and the next day Moroz sent a letter to Telus regarding his concerns.
A month later, the Progressive Conservatives brought up the outage in question period and Moroz didn't single out the company while answering questions, according to a official transcription of the legislative debate.
He only mentioned Telus by name on May 14, the day after he sold his shares, according to disclosure records.
The next day in question period, Moroz revealed he had read Telus's interim report about the phone outage.
"Mr. Moroz had a private interest, he owned shares in Telus Corporation. He sold those shares while being informed of an internal investigation into a system failure that disrupted access to emergency services," the PC complaint reads.
"This is a textbook example of making financial decisions related to information not available to the general public, and abusing access available solely as a result of his position as a minister of the Crown."
Moroz denied having privileged information. He called the Tory accusations "baseless."
"I acted based on publicly available information and media reporting. If the opposition had done their research properly, they also would have made this determination," he told reporters, who waited 46 minutes for Moroz to address media after the Progressive Conservatives answered questions on the ethics commissioner complaint.
Moroz said he was relying on publicly accessible information, such as Telus's letters to the Canadian Radio-television and Telecommunications Commission, which can be found online.
"We have no regulatory authority over telecommunications, so there is no conceivable inside information that I could have access to," Moroz said.
"Telus owes me nothing in terms of communication. In fact, neither the interim report nor the final report were sent to my office. I got them online with everyone else."
He added the ethics commissioner, with whom he met shortly after becoming a cabinet minister late last year, had no issue with him owning stocks in Telus.
Moroz said he went "above and beyond what's necessary" in choosing to sell the stocks. The minister's office said Moroz lost around $1,000 on the transaction, but his spokesperson didn't answer when asked about the value of the stocks he had in total.
'No impropriety:' Moroz
"What I wanted to make sure I did was make sure that not only was there no impropriety, but there's no appearance of impropriety."
Public disclosure records only require MLAs to list the shares, held by themselves, their spouse or dependents, in which the value exceeds $5,000.
Moroz added he sold his shares on May 8, but it took until May 13 for the change to be reflected in the disclosure records.
The PCs brought forward the new ethics complaint just days after the party was rapped by the ethics commissioner for trying to push through a silica sand mining project after losing the 2023 election. The commissioner recommended three senior Tories, including former premier Heather Stefanson, be fined between $10,000 and $18,000 each.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
3 minutes ago
- Globe and Mail
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
SASKATOON, SK , Aug. 15, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche") of its non-brokered private placement (the " Offering") of units of the Company (each a " Unit") for up to CAD $1,000,000 . Under the Second Tranche of the Offering, a further 140,845 Units were issued for aggregate gross proceeds of CAD $100,000 . The aggregate gross proceeds raised in the Second Tranche and first tranche of the Offering (which closed on July 29, 2025) (the " First Tranche") is approximately $0.42 million. The Company has issued a total of 591,126 Units each priced at $0.71 per Unit in the First Tranche and the Second Tranche. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (each Common Share purchase warrant, a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of 5 consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued under the First Tranche are subject to a hold period expiring November 30, 2025 , and all securities issued under the Second Tranche of the Offering are subject to a hold period expiring December 16, 2025 , in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.


CBC
4 minutes ago
- CBC
Burnaby company pitches plan to heat Kits Pool with bitcoin mining
A Burnaby company is proposing to heat Kitsilano Pool with excess heat from bitcoin mining. A UBC professor says the plan is energy inefficient, bad for Kits Pool, and bitcoin is a "slow-burning Ponzi scheme" with "no other use than to facilitate fraud, scams, and money laundering."


CBC
20 minutes ago
- CBC
Stellantis lays off 'small number' of workers in Windsor as company cuts back on EV muscle car
Stellantis is laying off workers at its assembly plant in Windsor, Ont., as the company shifts away from its electric muscle car. "A small number" of workers received layoff notices Friday, according to Stellantis spokesperson LouAnn Gosselin. "The layoffs are based on seniority and are a result of regular volume adjustments at the plant," Gosselin said. The company would not confirm the number of impacted employees. The union representing the plant's workers did not respond to a request for comment. The news comes on the last day of work before the plant's regular summer shutdown. It also comes at a time of heightened anxiety for auto workers in Canada, especially those in Windsor, where the economy relies heavily on the industry. Workers optimistic Employees at the Windsor assembly plant have faced temporary layoffs in recent months as a result of U.S. President Donald Trump's trade war with Canada and levies on the auto sector — though carve-outs for products that comply with CUSMA, the countries' existing trade deal, have softened the blow. The handful of workers who spoke to CBC Friday outside the Windsor assembly plant said they expect workers to be back on the job before long. "Could be a couple weeks," Emanuele Caruana said. "Right now things aren't looking too good, but they're going to be good soon." Dixon Bell described the layoffs as "not good" but said he too believed workers would be brought back eventually. Dave Lumley isn't worried at all, he said, and predicted the workers would be back on the job before Christmas. "It's just temporary," he said. "It's just a small amount. That happens a lot. It comes and goes. It's only 100 people." Lumley attributed the layoffs to changes in Dodge Charger production at the plant. "We have a battery area, and … we're not building batteries," he said. "Everybody wants gas, so they're trying to transition. That's mainly what it is." In May, Stellantis announced that it was postponing production of the Dodge Charger Daytona R/T, the base model of the first-of-their-kind electrified muscle cars, just a year after introducing them with great fanfare. The global automaker has blamed U.S. tariffs for the decision, but the move also followed weak sales amid a dampening EV market. Workers at the Windsor plant assemble both the Chargers and the company's minivan offerings, including the Chrysler Pacifica. Last week, Stellantis unveiled the 2026 Dodge Charger Scat Pack, equipped with an inline-six twin turbo engine, after months of pleading from gear heads to bring back gas-powered versions of the previously popular muscle cars.